Last 12 months
Inside the activity.
0 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 07, 2018 Filed May 9, 2018 18:35 UTC |
Alva Emily PetersonDirector
|
GrantRestricted Stock Units · Derivative | 6,107 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-012155 · doc4.xml · derivative · entry 2 Alva Emily Peterson · CIK 0001738422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,107 Underlying: Class A Common Stock · 6,107 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date. Read SEC document |
| May 07, 2018 Filed May 9, 2018 18:35 UTC |
Alva Emily PetersonDirector
|
GrantStock Option · Derivative | 24,977 | $0.00 Strike: $15.01 | $0.00 |
DisclosureSEC source: 0000899243-18-012155 · doc4.xml · derivative · entry 1 Alva Emily Peterson · CIK 0001738422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,977 Underlying: Class A Common Stock · 24,977 shares Expires 2028-05-07 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on May 07, 2019. Read SEC document |
| May 07, 2018 Filed May 9, 2018 22:34 UTC |
Patel ChintuDirector
|
GrantRestricted Stock Units · Derivative | 6,107 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-012152 · doc4.xml · derivative · entry 2 Patel Chintu · CIK 0001737428 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,107 Underlying: Class A Common Stock · 6,107 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date. Read SEC document |
| May 07, 2018 Filed May 9, 2018 22:34 UTC |
Patel ChintuDirector
|
GrantStock Option · Derivative | 24,977 | $0.00 Strike: $15.01 | $0.00 |
DisclosureSEC source: 0000899243-18-012152 · doc4.xml · derivative · entry 1 Patel Chintu · CIK 0001737428 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,977 Underlying: Class A Common Stock · 24,977 shares Expires 2028-05-07 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on May 07, 2019. Read SEC document |
| May 07, 2018 Filed May 9, 2018 22:41 UTC |
Greene Jean SeldenDirector
|
GrantRestricted Stock Units · Derivative | 6,107 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-012163 · doc4.xml · derivative · entry 2 Greene Jean Selden · CIK 0001738015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,107 Underlying: Class A Common Stock · 6,107 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date. Read SEC document |
| May 07, 2018 Filed May 9, 2018 22:41 UTC |
Greene Jean SeldenDirector
|
GrantStock Option · Derivative | 24,977 | $0.00 Strike: $15.01 | $0.00 |
DisclosureSEC source: 0000899243-18-012163 · doc4.xml · derivative · entry 1 Greene Jean Selden · CIK 0001738015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,977 Underlying: Class A Common Stock · 24,977 shares Expires 2028-05-07 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on May 07, 2019. Read SEC document |
| May 07, 2018 Filed May 9, 2018 22:39 UTC |
Rama DharmendraDirector
|
GrantRestricted Stock Units · Derivative | 6,107 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-012162 · doc4.xml · derivative · entry 2 Rama Dharmendra · CIK 0001738057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,107 Underlying: Class A Common Stock · 6,107 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date. Read SEC document |
| May 07, 2018 Filed May 9, 2018 22:39 UTC |
Rama DharmendraDirector
|
GrantStock Option · Derivative | 24,977 | $0.00 Strike: $15.01 | $0.00 |
DisclosureSEC source: 0000899243-18-012162 · doc4.xml · derivative · entry 1 Rama Dharmendra · CIK 0001738057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,977 Underlying: Class A Common Stock · 24,977 shares Expires 2028-05-07 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on May 07, 2019. Read SEC document |
| May 07, 2018 Filed May 9, 2018 22:36 UTC |
Patel GautamDirector
|
GrantRestricted Stock Units · Derivative | 6,107 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-012160 · doc4.xml · derivative · entry 2 Patel Gautam · CIK 0001738054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,107 Underlying: Class A Common Stock · 6,107 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date. Read SEC document |
| May 07, 2018 Filed May 9, 2018 22:36 UTC |
Patel GautamDirector
|
GrantStock Option · Derivative | 24,977 | $0.00 Strike: $15.01 | $0.00 |
DisclosureSEC source: 0000899243-18-012160 · doc4.xml · derivative · entry 1 Patel Gautam · CIK 0001738054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,977 Underlying: Class A Common Stock · 24,977 shares Expires 2028-05-07 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on May 07, 2019. Read SEC document |
| May 07, 2018 Filed May 9, 2018 22:36 UTC |
Patel Chirag K.Director
|
GrantRestricted Stock Units · Derivative | 6,107 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-012158 · doc4.xml · derivative · entry 2 Patel Chirag K. · CIK 0001738701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,107 Underlying: Class A Common Stock · 6,107 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date. Read SEC document |
| May 07, 2018 Filed May 9, 2018 22:36 UTC |
Patel Chirag K.Director
|
GrantStock Option · Derivative | 24,977 | $0.00 Strike: $15.01 | $0.00 |
DisclosureSEC source: 0000899243-18-012158 · doc4.xml · derivative · entry 1 Patel Chirag K. · CIK 0001738701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,977 Underlying: Class A Common Stock · 24,977 shares Expires 2028-05-07 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on May 07, 2019. Read SEC document |
| May 07, 2018 Filed May 9, 2018 22:36 UTC |
Nark Ted CDirector
|
GrantRestricted Stock Units · Derivative | 6,107 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-012157 · doc4.xml · derivative · entry 2 Nark Ted C · CIK 0001316851 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,107 Underlying: Class A Common Stock · 6,107 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date. Read SEC document |
| May 07, 2018 Filed May 9, 2018 22:36 UTC |
Nark Ted CDirector
|
GrantStock Option · Derivative | 24,977 | $0.00 Strike: $15.01 | $0.00 |
DisclosureSEC source: 0000899243-18-012157 · doc4.xml · derivative · entry 1 Nark Ted C · CIK 0001316851 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,977 Underlying: Class A Common Stock · 24,977 shares Expires 2028-05-07 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on May 07, 2019. Read SEC document |
| May 07, 2018 Filed May 9, 2018 22:35 UTC |
Shah NikitaSVP, Chief HR Officer
|
GrantRestricted Stock Units · Derivative | 17,766 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-012154 · doc4.xml · derivative · entry 2 Shah Nikita · CIK 0001738061 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,766 Underlying: Class A Common Stock · 17,766 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date. Read SEC document |
| May 07, 2018 Filed May 9, 2018 22:35 UTC |
Shah NikitaSVP, Chief HR Officer
|
GrantStock Option · Derivative | 72,661 | $0.00 Strike: $15.01 | $0.00 |
DisclosureSEC source: 0000899243-18-012154 · doc4.xml · derivative · entry 1 Shah Nikita · CIK 0001738061 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,661 Underlying: Class A Common Stock · 72,661 shares Expires 2028-05-07 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on May 07, 2019. Read SEC document |
| May 07, 2018 Filed May 9, 2018 22:33 UTC |
Stewart Robert ADirector · President & CEO
|
GrantRestricted Stock Units · Derivative | 333,111 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-012150 · doc4.xml · derivative · entry 2 Stewart Robert A · CIK 0001476493 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,111 Underlying: Class A Common Stock · 333,111 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date. Read SEC document |
| May 07, 2018 Filed May 9, 2018 22:33 UTC |
Stewart Robert ADirector · President & CEO
|
GrantStock Option · Derivative | 681,199 | $0.00 Strike: $15.01 | $0.00 |
DisclosureSEC source: 0000899243-18-012150 · doc4.xml · derivative · entry 1 Stewart Robert A · CIK 0001476493 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 681,199 Underlying: Class A Common Stock · 681,199 shares Expires 2028-05-07 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on May 07, 2019. Read SEC document |
| May 07, 2018 Filed May 9, 2018 22:33 UTC |
Hirt SheldonSVP, GC & Corp Sec
|
GrantRestricted Stock Units · Derivative | 17,766 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-012147 · doc4.xml · derivative · entry 2 Hirt Sheldon · CIK 0001647557 · SVP, GC & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,766 Underlying: Class A Common Stock · 17,766 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date. Read SEC document |
| May 07, 2018 Filed May 9, 2018 22:33 UTC |
Hirt SheldonSVP, GC & Corp Sec
|
GrantStock Option · Derivative | 72,661 | $0.00 Strike: $15.01 | $0.00 |
DisclosureSEC source: 0000899243-18-012147 · doc4.xml · derivative · entry 1 Hirt Sheldon · CIK 0001647557 · SVP, GC & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,661 Underlying: Class A Common Stock · 72,661 shares Expires 2028-05-07 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on May 07, 2019. Read SEC document |
| May 04, 2018 Filed May 8, 2018 19:28 UTC |
APHC Holdings, LLC10% owner
|
ConversionCommon Units · Derivative | 12,328,767 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-011952 · doc4.xml · derivative · entry 7 APHC Holdings, LLC · CIK 0001739290 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,260,707 Underlying: Class B-1 Common Stock · 12,328,767 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Common Units may be redeemed by the Reporting Person at any time for shares of the Issuer's Class A Common Stock or Class B-1 Common Stock on a 1-to-1 basis. F2 · derivative.exercise_date: The Common Units may be redeemed by the Reporting Person at any time for shares of the Issuer's Class A Common Stock or Class B-1 Common Stock on a 1-to-1 basis. F2 · derivative.expiration_date: The Common Units may be redeemed by the Reporting Person at any time for shares of the Issuer's Class A Common Stock or Class B-1 Common Stock on a 1-to-1 basis. Read SEC document |
| May 04, 2018 Filed May 8, 2018 19:28 UTC |
APHC Holdings, LLC10% owner
|
ConversionCommon Units · Derivative | 41,406,689 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-011952 · doc4.xml · derivative · entry 6 APHC Holdings, LLC · CIK 0001739290 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,589,474 Underlying: Class A Common Stock · 41,406,689 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Common Units may be redeemed by the Reporting Person at any time for shares of the Issuer's Class A Common Stock or Class B-1 Common Stock on a 1-to-1 basis. F2 · derivative.exercise_date: The Common Units may be redeemed by the Reporting Person at any time for shares of the Issuer's Class A Common Stock or Class B-1 Common Stock on a 1-to-1 basis. F2 · derivative.expiration_date: The Common Units may be redeemed by the Reporting Person at any time for shares of the Issuer's Class A Common Stock or Class B-1 Common Stock on a 1-to-1 basis. Read SEC document |
| May 04, 2018 Filed May 8, 2018 19:28 UTC |
APHC Holdings, LLC10% owner
|
OtherClass B Common Stock | 53,735,465 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-011952 · doc4.xml · nonDerivative · entry 5 APHC Holdings, LLC · CIK 0001739290 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,260,707 F1 · kind: Reflects the cancellation for no consideration of Class B Common Stock in connection with the redemption of the Common Units. Read SEC document |
| May 04, 2018 Filed May 8, 2018 19:28 UTC |
APHC Holdings, LLC10% owner
|
SaleClass B-1 Common Stock | 12,328,767 | $18.25 | $224,999,997.75 |
DisclosureSEC source: 0000899243-18-011952 · doc4.xml · nonDerivative · entry 4 APHC Holdings, LLC · CIK 0001739290 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| May 04, 2018 Filed May 8, 2018 19:28 UTC |
APHC Holdings, LLC10% owner
|
SaleClass A Common Stock | 34,520,549 | $18.25 | $630,000,019.25 |
DisclosureSEC source: 0000899243-18-011952 · doc4.xml · nonDerivative · entry 3 APHC Holdings, LLC · CIK 0001739290 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,886,140 Read SEC document |
| May 04, 2018 Filed May 8, 2018 19:28 UTC |
APHC Holdings, LLC10% owner
|
ConversionClass B-1 Common Stock | 12,328,767 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-011952 · doc4.xml · nonDerivative · entry 2 APHC Holdings, LLC · CIK 0001739290 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,328,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2018 Filed May 8, 2018 19:28 UTC |
APHC Holdings, LLC10% owner
|
ConversionClass A Common Stock | 41,406,689 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-011952 · doc4.xml · nonDerivative · entry 1 APHC Holdings, LLC · CIK 0001739290 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,406,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:27 UTC |
BOYER ANDREW SExec VP, Comm Optns
|
GrantClass A Common Stock | 2,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-011951 · doc4.xml · nonDerivative · entry 1 BOYER ANDREW S · CIK 0001239546 · Exec VP, Comm Optns 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F1 · price: Received in exchange for 2,000 shares of Impax Laboratories, Inc. ("Impax") common stock pursuant to the Business Combination Agreement, dated as of October 17, 2017, among Impax, Amneal Pharmaceuticals LLC, Atlas Holdings, Inc. and K2 Merger Sub Corporation (as amended, the "BCA"). Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:26 UTC |
Vergis Janet S.Director
|
GrantStock Option · Derivative | 8,100 | Not disclosed Strike: $38.42 | Not disclosed |
DisclosureSEC source: 0000899243-18-011950 · doc4.xml · derivative · entry 4 Vergis Janet S. · CIK 0001590794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,100 Underlying: Class A Common Stock · 8,100 shares Expires 2025-10-07 F3 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F2 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:26 UTC |
Vergis Janet S.Director
|
GrantStock Option · Derivative | 10,575 | Not disclosed Strike: $30.33 | Not disclosed |
DisclosureSEC source: 0000899243-18-011950 · doc4.xml · derivative · entry 3 Vergis Janet S. · CIK 0001590794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,575 Underlying: Class A Common Stock · 10,575 shares Expires 2026-05-17 F3 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F2 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:26 UTC |
Vergis Janet S.Director
|
GrantStock Option · Derivative | 10,575 | Not disclosed Strike: $16.40 | Not disclosed |
DisclosureSEC source: 0000899243-18-011950 · doc4.xml · derivative · entry 2 Vergis Janet S. · CIK 0001590794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,575 Underlying: Class A Common Stock · 10,575 shares Expires 2027-05-16 F3 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F2 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:26 UTC |
Vergis Janet S.Director
|
GrantClass A Common Stock | 12,150 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-011950 · doc4.xml · nonDerivative · entry 1 Vergis Janet S. · CIK 0001590794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,150 F1 · price: Received in exchange for 12,150 shares of Impax Laboratories, Inc. ("Impax") common stock pursuant to the Business Combination Agreement, dated as of October 17, 2017, among Impax, Amneal Pharmaceuticals LLC, Atlas Holdings, Inc. and K2 Merger Sub Corporation (as amended, the "BCA"). Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:26 UTC |
BUCHI J KEVINDirector
|
GrantStock Option · Derivative | 20,445 | Not disclosed Strike: $14.45 | Not disclosed |
DisclosureSEC source: 0000899243-18-011948 · doc4.xml · derivative · entry 3 BUCHI J KEVIN · CIK 0001209726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,445 Underlying: Class A Common Stock · 20,445 shares Expires 2026-11-23 F3 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F2 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:26 UTC |
BUCHI J KEVINDirector
|
GrantStock Option · Derivative | 7,931 | Not disclosed Strike: $16.40 | Not disclosed |
DisclosureSEC source: 0000899243-18-011948 · doc4.xml · derivative · entry 2 BUCHI J KEVIN · CIK 0001209726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,931 Underlying: Class A Common Stock · 7,931 shares Expires 2027-05-16 F3 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F2 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:26 UTC |
BUCHI J KEVINDirector
|
GrantClass A Common Stock | 11,301 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-011948 · doc4.xml · nonDerivative · entry 1 BUCHI J KEVIN · CIK 0001209726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,301 F1 · price: Received in exchange for 11,301 shares of Impax Laboratories, Inc. ("Impax") common stock pursuant to the Business Combination Agreement, dated as of October 17, 2017, among Impax, Amneal Pharmaceuticals LLC, Atlas Holdings, Inc. and K2 Merger Sub Corporation (as amended, the "BCA"). Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:25 UTC |
TERRERI PETER RDirector
|
GrantStock Option · Derivative | 45,000 | Not disclosed Strike: $6.55 | Not disclosed |
DisclosureSEC source: 0000899243-18-011946 · doc4.xml · derivative · entry 10 TERRERI PETER R · CIK 0001238456 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Class A Common Stock · 45,000 shares Expires 2019-05-20 F3 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F2 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:25 UTC |
TERRERI PETER RDirector
|
GrantStock Option · Derivative | 10,000 | Not disclosed Strike: $20.30 | Not disclosed |
DisclosureSEC source: 0000899243-18-011946 · doc4.xml · derivative · entry 9 TERRERI PETER R · CIK 0001238456 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Class A Common Stock · 10,000 shares Expires 2020-05-26 F3 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F2 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:25 UTC |
TERRERI PETER RDirector
|
GrantStock Option · Derivative | 10,000 | Not disclosed Strike: $27.97 | Not disclosed |
DisclosureSEC source: 0000899243-18-011946 · doc4.xml · derivative · entry 8 TERRERI PETER R · CIK 0001238456 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Class A Common Stock · 10,000 shares Expires 2021-05-11 F3 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F2 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:25 UTC |
TERRERI PETER RDirector
|
GrantStock Option · Derivative | 10,000 | Not disclosed Strike: $20.90 | Not disclosed |
DisclosureSEC source: 0000899243-18-011946 · doc4.xml · derivative · entry 7 TERRERI PETER R · CIK 0001238456 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Class A Common Stock · 10,000 shares Expires 2022-05-23 F3 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F2 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:25 UTC |
TERRERI PETER RDirector
|
GrantStock Option · Derivative | 12,000 | Not disclosed Strike: $17.99 | Not disclosed |
DisclosureSEC source: 0000899243-18-011946 · doc4.xml · derivative · entry 6 TERRERI PETER R · CIK 0001238456 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Class A Common Stock · 12,000 shares Expires 2023-05-15 F3 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F2 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:25 UTC |
TERRERI PETER RDirector
|
GrantStock Option · Derivative | 11,500 | Not disclosed Strike: $25.24 | Not disclosed |
DisclosureSEC source: 0000899243-18-011946 · doc4.xml · derivative · entry 5 TERRERI PETER R · CIK 0001238456 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,500 Underlying: Class A Common Stock · 11,500 shares Expires 2024-05-14 F3 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F2 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:25 UTC |
TERRERI PETER RDirector
|
GrantStock Option · Derivative | 7,300 | Not disclosed Strike: $44.85 | Not disclosed |
DisclosureSEC source: 0000899243-18-011946 · doc4.xml · derivative · entry 4 TERRERI PETER R · CIK 0001238456 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,300 Underlying: Class A Common Stock · 7,300 shares Expires 2025-05-12 F3 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F2 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:25 UTC |
TERRERI PETER RDirector
|
GrantStock Option · Derivative | 10,575 | Not disclosed Strike: $30.33 | Not disclosed |
DisclosureSEC source: 0000899243-18-011946 · doc4.xml · derivative · entry 3 TERRERI PETER R · CIK 0001238456 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,575 Underlying: Class A Common Stock · 10,575 shares Expires 2026-05-17 F3 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F2 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:25 UTC |
TERRERI PETER RDirector
|
GrantStock Option · Derivative | 10,575 | Not disclosed Strike: $16.40 | Not disclosed |
DisclosureSEC source: 0000899243-18-011946 · doc4.xml · derivative · entry 2 TERRERI PETER R · CIK 0001238456 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,575 Underlying: Class A Common Stock · 10,575 shares Expires 2027-05-16 F3 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F2 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:25 UTC |
TERRERI PETER RDirector
|
GrantClass A Common Stock | 48,537 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-011946 · doc4.xml · nonDerivative · entry 1 TERRERI PETER R · CIK 0001238456 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,537 F1 · price: Received in exchange for 48,537 shares of Impax Laboratories, Inc. ("Impax") common stock pursuant to the Business Combination Agreement, dated as of October 17, 2017, among Impax, Amneal Pharmaceuticals LLC, Atlas Holdings, Inc. and K2 Merger Sub Corporation (as amended, the "BCA"). Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:23 UTC |
BURR ROBERT LDirector
|
GrantStock Option · Derivative | 30,000 | Not disclosed Strike: $6.55 | Not disclosed |
DisclosureSEC source: 0000899243-18-011945 · doc4.xml · derivative · entry 11 BURR ROBERT L · CIK 0001245188 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Class A Common Stock · 30,000 shares Expires 2019-05-20 F4 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F3 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:23 UTC |
BURR ROBERT LDirector
|
GrantStock Option · Derivative | 10,000 | Not disclosed Strike: $20.30 | Not disclosed |
DisclosureSEC source: 0000899243-18-011945 · doc4.xml · derivative · entry 10 BURR ROBERT L · CIK 0001245188 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Class A Common Stock · 10,000 shares Expires 2020-05-26 F4 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F3 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:23 UTC |
BURR ROBERT LDirector
|
GrantStock Option · Derivative | 10,000 | Not disclosed Strike: $27.97 | Not disclosed |
DisclosureSEC source: 0000899243-18-011945 · doc4.xml · derivative · entry 9 BURR ROBERT L · CIK 0001245188 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Class A Common Stock · 10,000 shares Expires 2021-05-11 F4 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F3 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:23 UTC |
BURR ROBERT LDirector
|
GrantStock Option · Derivative | 10,000 | Not disclosed Strike: $20.90 | Not disclosed |
DisclosureSEC source: 0000899243-18-011945 · doc4.xml · derivative · entry 8 BURR ROBERT L · CIK 0001245188 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Class A Common Stock · 10,000 shares Expires 2022-05-23 F4 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F3 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:23 UTC |
BURR ROBERT LDirector
|
GrantStock Option · Derivative | 12,000 | Not disclosed Strike: $17.99 | Not disclosed |
DisclosureSEC source: 0000899243-18-011945 · doc4.xml · derivative · entry 7 BURR ROBERT L · CIK 0001245188 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Class A Common Stock · 12,000 shares Expires 2023-05-15 F4 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F3 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.